Oils4cure: finding an effective drug to alleviate Refractory Epilepsy, one of the most severe symptoms in the pathology of Tuberous Sclerosis

€2.23M EUR

Funder	European Commission
Recipient Organization	Oils4Cure Sl
Country	Spain
Start Date	Dec 01, 2023
End Date	Nov 30, 2025
Duration	730 days
Number of Grantees	1
Roles	Coordinator
Data Source	European Commission
Grant ID	`190119321`

Grant Description

OILS4CURE is a Spanish biotech company dedicated to the research, development, production and commercialisation of medicinal products based on a medicinal cannabis extract.

It is developing a drug to manage refractory epilepsy associated with tuberous sclerosis (YCJ-01) and another for Leukodystrophies (YCJ-02), both are paediatric rare diseases.

This project only deals with the development of our first and most advanced therapy directed at tuberous sclerosis (TS).